Travere Therapeutics TVTX
NASDAQ TVTX
$65.28 -1.26 (-1.89%)
As of: Sep 4, 2026 · 3:59 PM EDT

Travere Therapeutics (TVTX) Shares Issued (2013 - 2017)

Analysis

Travere Therapeutics (TVTX) Shares Issued (2013 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Travere Therapeutics 6.11 Bn 6.11 Bn 162.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 39.37 Mn
Dec 31, 2016 37.91 Mn
Dec 31, 2015 36.47 Mn
Dec 31, 2014 26.43 Mn
Dec 31, 2013 18.55 Mn